Diabetes drug Byetta linked to injuries and death
Deaths have been reported in connection with the widely used diabetes drug, Byetta (exenatide), marketed by Amylin Pharmaceuticals and Eli Lilly & Co. An alert from the FDA said they have received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta. Byetta is a medicine given by subcutaneous injection to help treat adults with type 2 diabetes. Of the 6 cases of hemorrhagic or necrotizing pancreatitis, all patients required hospitalization, two patients died and four patients were recovering at the time of reporting. Byetta was discontinued in all 6 cases. Federal regulators are working on a stronger label fo the drug.
If you or a loved one have been seriously injured by a defective pharmaceutical drug like Byetta, you may be entitled to compensation from those responsible for your injury. Contact the medical injury lawyers at the Arnold & Itkin LLP law firm in Houston, Texas to learn more about your options.
